NEW YORK—June 30, 2009
“We emphasize infection control as a best practice,” said Thomas P. Sculco, M.D., surgeon–in-chief of Hospital for Special Surgery, “and strive to maintain it at every level of patient care - from washing hands to a clean and safe environment for our patients in the operating room and the entire hospital.”
The report comparisons also found that hospitals performing fewer than 50 hip replacements/revisions per year had a significantly higher risk for SSI than others. Out of the 171 hospitals in New York State, which collectively performed 23,611 hip replacements/revisions last year, Special Surgery performed almost 3,700, the state’s highest surgical volume coupled with a significantly lower SSI rate when compared to the state average.
“At Hospital for Special Surgery, we believe that infection control is everyone’s responsibility,” said Louis A. Shapiro, President and CEO. “Efforts to prevent infection are woven into the fabric of this organization and it takes everyone’s contributions, from surgeons and nurses to housekeepers and technicians, to achieve success.”
New York State has one of the strictest regulatory and surveillance systems for hospitals in the country. The law mandates that New York’s 186 hospitals document and report certain hospital acquired infections to the New York State Department of Health. The report issued today says key goals are to provide the public with fair, accurate and reliable infection data as well as to support the improvement of infection control activities in hospitals. Today's release marks the second year for the report, but the first to include SSI of hip replacement/revision surgery data.
View the New York State Department of Health's full report.
About HSS | Hospital for Special Surgery
HSS is the world’s leading academic medical center focused on musculoskeletal health. At its core is Hospital for Special Surgery, nationally ranked No. 1 in orthopedics (for the eighth consecutive year) and No. 3 in rheumatology by U.S. News & World Report (2017-2018). Founded in 1863, the Hospital has one of the lowest infection rates in the country and was the first in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center four consecutive times. The global standard total knee replacement was developed at HSS in 1969. An affiliate of Weill Cornell Medical College, HSS has a main campus in New York City and facilities in New Jersey, Connecticut and in the Long Island and Westchester County regions of New York State. In 2017 HSS provided care to 135,000 patients and performed more than 32,000 surgical procedures. People from all 50 U.S. states and 80 countries travelled to receive care at HSS. In addition to patient care, HSS leads the field in research, innovation and education. The HSS Research Institute comprises 20 laboratories and 300 staff members focused on leading the advancement of musculoskeletal health through prevention of degeneration, tissue repair and tissue regeneration. The HSS Global Innovation Institute was formed in 2016 to realize the potential of new drugs, therapeutics and devices. The culture of innovation is accelerating at HSS as 130 new idea submissions were made to the Global Innovation Institute in 2017 (almost 3x the submissions in 2015). The HSS Education Institute is the world’s leading provider of education on the topic on musculoskeletal health, with its online learning platform offering more than 600 courses to more than 21,000 medical professional members worldwide. Through HSS Global Ventures, the institution is collaborating with medical centers and other organizations to advance the quality and value of musculoskeletal care and to make world-class HSS care more widely accessible nationally and internationally.